{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:10:28Z","timestamp":1778638228604,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01 BX001067-01A2"],"award-info":[{"award-number":["1I01 BX001067-01A2"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX004739-01A2"],"award-info":[{"award-number":["1I01BX004739-01A2"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020875","name":"Midwest Veterans&apos; Biomedical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["NPSPAD-11-202149"],"award-info":[{"award-number":["NPSPAD-11-202149"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["NPSPAD1-11\\u2013202149"],"award-info":[{"award-number":["NPSPAD1-11\\u2013202149"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jbc.2024.107619","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T19:57:32Z","timestamp":1722628652000},"page":"107619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proactive M2 blockade prevents cognitive decline in GRK5-deficient APP transgenic mice via enhancing cholinergic neuronal resilience"],"prefix":"10.1016","volume":"300","author":[{"given":"Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhakar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7993-8629","authenticated-orcid":false,"given":"Evelyn Y.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery M.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0751-5050","authenticated-orcid":false,"given":"William Z.","family":"Suo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2024.107619_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/alz.13016","article-title":"2023 Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jbc.2024.107619_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer's disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jbc.2024.107619_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/547153a","article-title":"Stop Alzheimer's before it starts","volume":"547","author":"McDade","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2024.107619_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s13311-022-01185-z","article-title":"Heterogeneity in Alzheimer's disease diagnosis and progression rates: implications for therapeutic trials","volume":"19","author":"Duara","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jbc.2024.107619_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jbc.2024.107619_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-019-02054-4","article-title":"The basis of cellular and regional vulnerability in Alzheimer's disease","volume":"138","author":"Mrdjen","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2024.107619_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neuron.2020.06.010","article-title":"Selective neuronal vulnerability in Alzheimer's disease: a network-based analysis","volume":"107","author":"Roussarie","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.107619_bib8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107619_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.293re8","article-title":"G\u00a0protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease","volume":"2","author":"Thathiah","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2024.107619_bib10","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.281.15.1401","article-title":"Cholinergic markers in elderly patients with early signs of Alzheimer disease","volume":"281","author":"Davis","year":"1999","journal-title":"Jama"},{"key":"10.1016\/j.jbc.2024.107619_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jbc.2024.107619_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/(SICI)1096-9861(19990906)411:4<693::AID-CNE13>3.0.CO;2-D","article-title":"Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease","volume":"411","author":"Gilmor","year":"1999","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.jbc.2024.107619_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0011-393X(03)00059-6","article-title":"Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on","volume":"64","author":"Grossberg","year":"2003","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.jbc.2024.107619_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer's disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement. (N Y)"},{"key":"10.1016\/j.jbc.2024.107619_bib15","doi-asserted-by":"crossref","first-page":"13900","DOI":"10.3390\/ijms241813900","article-title":"Treatment of Alzheimer's disease: beyond symptomatic therapies","volume":"24","author":"Buccellato","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2024.107619_bib16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cercor\/bhp232","article-title":"Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease","volume":"20","author":"Grothe","year":"2010","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.jbc.2024.107619_bib17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.biopsych.2011.06.019","article-title":"Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease","volume":"71","author":"Grothe","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jbc.2024.107619_bib18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hbm.21111","article-title":"The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in\u00a0vivo MRI and DTI study","volume":"32","author":"Teipel","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jbc.2024.107619_bib19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1523\/JNEUROSCI.3617-14.2015","article-title":"Cholinergic basal forebrain structure influences the reconfiguration of white matter connections to support residual memory in mild cognitive impairment","volume":"35","author":"Ray","year":"2015","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2024.107619_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnagi.2015.00185","article-title":"Basal forebrain atrophy contributes to allocentric navigation impairment in Alzheimer's disease patients","volume":"7","author":"Kerbler","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jbc.2024.107619_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13249","article-title":"Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology","volume":"7","author":"Schmitz","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2024.107619_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09780-3","article-title":"Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer's disease","volume":"7","author":"Cavedo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.107619_bib23","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.neuron.2016.09.006","article-title":"Basal forebrain cholinergic circuits and signaling in cognition and cognitive decline","volume":"91","author":"Ballinger","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.107619_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.biochem.67.1.653","article-title":"G\u00a0protein-coupled receptor kinases","volume":"67","author":"Pitcher","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2024.107619_bib25","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1100\/tsw.2010.154","article-title":"Dysfunction of G protein-coupled receptor kinases in Alzheimer's disease","volume":"10","author":"Suo","year":"2010","journal-title":"TheScientificWorldJournal"},{"key":"10.1016\/j.jbc.2024.107619_bib26","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.1221820110","article-title":"Profile of Brian K. Kobilka and Robert J. Lefkowitz, 2012 Nobel laureates in chemistry","volume":"110","author":"Clark","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107619_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/mol.63.1.9","article-title":"Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization","volume":"63","author":"Kohout","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107619_bib28","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0896-6273(00)81048-X","article-title":"Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice","volume":"24","author":"Gainetdinov","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.107619_bib29","doi-asserted-by":"crossref","first-page":"12974","DOI":"10.1073\/pnas.93.23.12974","article-title":"Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function","volume":"93","author":"Jaber","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2024.107619_bib30","doi-asserted-by":"crossref","first-page":"25425","DOI":"10.1074\/jbc.272.41.25425","article-title":"G\u00a0protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization","volume":"272","author":"Peppel","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107619_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0896-6273(03)00192-2","article-title":"Dopaminergic supersensitivity in g protein-coupled receptor kinase 6-deficient mice","volume":"38","author":"Gainetdinov","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2024.107619_bib32","doi-asserted-by":"crossref","first-page":"19564","DOI":"10.1074\/jbc.M109.005959","article-title":"GRK5 deficiency leads to reduced hippocampal acetylcholine level via impaired presynaptic M2\/M4 autoreceptor desensitization","volume":"284","author":"Liu","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107619_bib33","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3233\/JAD-215379","article-title":"GRK5 deficiency causes mild cognitive impairment due to Alzheimer's disease","volume":"85","author":"Suo","year":"2022","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.jbc.2024.107619_bib34","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1523\/JNEUROSCI.4856-03.2004","article-title":"Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer's disease: an association with early beta-amyloid accumulation","volume":"24","author":"Suo","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2024.107619_bib35","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.neurobiolaging.2006.08.013","article-title":"GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment","volume":"28","author":"Suo","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jbc.2024.107619_bib36","doi-asserted-by":"crossref","first-page":"41541","DOI":"10.1074\/jbc.M110.170894","article-title":"GRK5 deficiency accelerates b-amyloid accumulation in Tg2576 mice via impaired cholinergic activity","volume":"285","author":"Cheng","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2024.107619_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-5-24","article-title":"GRK5 deficiency exaggerates inflammatory changes in TgAPPsw mice","volume":"5","author":"Li","year":"2008","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.jbc.2024.107619_bib38","article-title":"GRK5 deficiency leads to selective basal forebrain cholinergic neuronal vulnerability","volume":"6","author":"He","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2024.107619_bib39","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/bph.12431","article-title":"Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway","volume":"171","author":"Roy","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107619_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2024.107619_bib41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bcp.2019.01.015","article-title":"A\u00a0delicate balance - the BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics","volume":"162","author":"Knight","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2024.107619_bib42","first-page":"1837","article-title":"Potential role of the cAMP\/PKA\/CREB signalling pathway in hypoxic preconditioning and effect on propofol-induced neurotoxicity in the hippocampus of neonatal rats","volume":"20","author":"Guan","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jbc.2024.107619_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nm0502-450","article-title":"CREB family transcription factors inhibit neuronal suicide","volume":"8","author":"Dawson","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2024.107619_bib44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4236\/aad.2013.24020","article-title":"Accelerating Alzheimer\u2019s pathogenesis by GRK5 deficiency via cholinergic dysfunction","volume":"2","author":"Suo","year":"2013","journal-title":"Adv. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.jbc.2024.107619_bib45","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2024.107619_bib46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bmc.2003.11.005","article-title":"Muscarinic M2 antagonists: anthranilamide derivatives with exceptional selectivity and in\u00a0vivo activity","volume":"12","author":"Clader","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jbc.2024.107619_bib47","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbc.2024.107619_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbr.2016.01.019","article-title":"GRK5 deficiency leads to susceptibility to intermittent hypoxia-induced cognitive impairment","volume":"302","author":"Singh","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jbc.2024.107619_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.jbc.2024.107619_bib50","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cub.2018.02.048","article-title":"A\u00a0cAMP\/PKA\/Kinesin-1 axis promotes the axonal transport of mitochondria in aging Drosophila neurons","volume":"28","author":"Vagnoni","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2024.107619_bib51","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.1411529","article-title":"Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors","volume":"258","author":"Nitsch","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.jbc.2024.107619_bib52","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1139\/jpn.0442","article-title":"Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease","volume":"29","author":"Kar","year":"2004","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.jbc.2024.107619_bib53","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s40265-023-01858-9","article-title":"Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer's disease therapeutics","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jbc.2024.107619_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1755-5949.2010.00175.x","article-title":"Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?","volume":"16","author":"Martorana","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jbc.2024.107619_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer's disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal. Transduct. Target Ther."},{"key":"10.1016\/j.jbc.2024.107619_bib56","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/biom10010040","article-title":"Alzheimer's disease pharmacotherapy in relation to cholinergic system involvement","volume":"10","author":"Stanciu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jbc.2024.107619_bib57","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jamda.2015.08.019","article-title":"A\u00a0randomized placebo-controlled discontinuation study of cholinesterase inhibitors in institutionalized patients with moderate to severe Alzheimer disease","volume":"17","author":"Herrmann","year":"2016","journal-title":"J.\u00a0Am. Med. Dir. Assoc."},{"key":"10.1016\/j.jbc.2024.107619_bib58","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10072-012-0938-8","article-title":"Withdrawal syndrome after donepezil cessation in a patient with dementia","volume":"33","author":"Bidzan","year":"2012","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jbc.2024.107619_bib59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/gps.811","article-title":"Discontinuation syndrome following donepezil cessation","volume":"18","author":"Singh","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jbc.2024.107619_bib60","first-page":"CD009081","article-title":"Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia","volume":"2","author":"Parsons","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jbc.2024.107619_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainresbull.2008.09.019","article-title":"Augmented axonal defects and synaptic degenerative changes in female GRK5 deficient mice","volume":"78","author":"Li","year":"2009","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jbc.2024.107619_bib62","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nbd.2003.08.009","article-title":"Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice","volume":"14","author":"Wang","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jbc.2024.107619_bib63","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cns.12394","article-title":"An improved elevated platform for simultaneously assessing rodent locomotor activity and anxiety","volume":"21","author":"Ding","year":"2015","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jbc.2024.107619_bib64","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-021-00073-z","article-title":"APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer's mice via cyclophilin A independently of amyloid-beta","volume":"1","author":"Montagne","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.jbc.2024.107619_bib65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neulet.2012.01.033","article-title":"Hippocampal neurotransmitter efflux during one-trial novel object recognition in rats","volume":"511","author":"Stanley","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jbc.2024.107619_bib66","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","article-title":"Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator","volume":"231","author":"West","year":"1991","journal-title":"Anatomical. Rec."},{"key":"10.1016\/j.jbc.2024.107619_bib67","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-8993(02)03475-3","article-title":"Age and gender effects on microglia and astrocyte numbers in brains of mice","volume":"956","author":"Mouton","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.jbc.2024.107619_bib68","doi-asserted-by":"crossref","DOI":"10.3791\/60405","article-title":"Stereological estimation of cholinergic fiber Length in the nucleus basalis of Meynert of the mouse brain","author":"Singh","year":"2020","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.jbc.2024.107619_bib69","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824021203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925824021203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:27:20Z","timestamp":1778635640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925824021203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0021925824021203"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107619","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proactive M2 blockade prevents cognitive decline in GRK5-deficient APP transgenic mice via enhancing cholinergic neuronal resilience","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2024.107619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"107619"}}